Angiotensin-Converting Enzymes: Properties and Function

Hypertension

Volumn , Issue , 2005, Pages 95-99

  Tikellis, Chris ^a   Johnston, Colin I ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 43049160030     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0258-5.50099-5     Document Type: Chapter

References (68)

1. Johnston CI Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J Hypertens Suppl 1992, 10:S13-S26.
2. Dzau VJ, Bernstein K, Celermajer D, et al. The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data. Am J Cardiol 2001, 88:1L-20L.
3. Erdos EG Conversion of angiotensin I to angiotensin II. Am J Med 1976, 60:749-759.
4. Paul M, Stoll M, Kreutz R, et al. The cellular basis of angiotensin converting enzyme mRNA expression in rat heart. Basic Res Cardiol 91 Suppl 1996, 2:57-63.
5. Alhenc-Gelas F, Baussant T, Hubert C, et al. The angiotensin converting enzyme in the kidney. J Hypertens Suppl 1989, 7:S9-S13; discussion S14.
6. Erickson RH, Suzuki Y, Sedlmayer A, et al. Rat intestinal angiotensin-converting enzyme: purification, properties, expression, and function. Am J Physiol 1992, 263:G466-G473.
7. Whiting P, Nava S, Mozley L, et al. Expression of angiotensin converting enzyme mRNA in rat brain. Brain Res Mol Brain Res 1991, 11:93-96.
8. Sibony M, Segretain D, Gasc JM Angiotensin-converting enzyme in murine testis: Step-specific expression of the germinal isoform during spermiogenesis. Biol Reprod 1994, 50:1015-1026.
9. Esther CR, Howard TE, Marino EM, et al. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 1996, 74:953-965.
10. Turner AJ, Hooper NM The angiotensin-converting enzyme gene family: Genomics and pharmacology. Trends Pharmacol Sci 2002, 23:177-183.
11. Cole JM, Khokhlova N, Sutliff RL, et al. Mice lacking endothelial ACE: normal blood pressure with elevated angiotensin II. Hypertension 2003, 41:313-321.
12. Cole J, Ertoy D, Bernstein KE Insights derived from ACE knockout mice. J Renin Angiotensin Aldosterone Syst 2000, 1:137-141.
13. Tipnis SR, Hooper NM, Hyde R, et al. A human homolog of angiotensin-converting enzyme: Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000, 275:33238-33243.
14. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000, 87:E1-E9.
15. Vickers C, Hales P, Kaushik V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002, 277:14838-14843.
16. Harmer D, Gilbert M, Borman R, et al. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett 2002, 532:107-110.
17. Haulica I, Bild W, Mihaila CN, et al. Biphasic effects of angiotensin (1-7) and its interactions with angiotensin II in rat aorta. J Renin Angiotensin Aldosterone Syst 2003, 4:124-128.
18. Brosnihan KB, Li P, Ferrario CM Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996, 27:523-528.
19. Porsti I, Bara AT, Busse R, et al. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: Implications for a novel angiotensin receptor. Br J Pharmacol 1994, 111:652-654.
20. Benter IF, Diz DI, Ferrario CM Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7). Hypertension 1995, 26:1138-1144.
21. Benter IF, Ferrario CM, Morris M, et al. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol 1995, 269:H313-H319.
22. Ferrario CM, Chappell MC, Tallant EA, et al. Counterregulatory actions of angiotensin-(1-7). Hypertension 1997, 30:535-541.
23. Hilchey SD, Bell-Quilley CP Association between the natriuretic action of angiotensin-(1-7) and selective stimulation of renal prostaglandin I2 release. Hypertension 1995, 25:1238-1244.
24. Machado RD, Santos RA, Andrade SP Opposing actions of angiotensins on angiogenesis. Life Sci 2000, 66:67-76.
25. Kucharewicz I, Chabielska E, Pawlak D, et al. The antithrombotic effect of angiotensin-(1-7) closely resembles that of losar-tan. J Renin Angiotensin Aldosterone Syst 2000, 1:268-272.
26. Freeman EJ, Chisolm GM, Ferrario CM, et al. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996, 28:104-108.
27. Tallant EA, Lu X, Weiss RB, et al. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension 1997, 29:388-393.
28. Santos RA, Simoes e Silva AC, Maric C, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003, 100(14):8258-8263. Epub 2003 Jun 26.
29. Chappell MC, Pirro NT, Sykes A, et al. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension 1998, 31:362-367.
30. Dales NA, Gould AE, Brown JA, et al. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J Am Chem Soc 2002, 124:11852-11853.
31. Crackower MA, Sarao R, Oudit GY, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002, 417:822-828.
32. Zisman LS, Keller RS, Weaver B, et al. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2. Circulation 2003, 108:1707-1712.
33. Donoghue M, Wakimoto H, Maguire CT, et al. Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins. J Mol Cell Cardiol 2003, 35:1043-1053.
34. Anderson S, Jung FF, Ingelfinger JR Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 1993, 265:F477-F486.
35. Tikellis C, Johnston CI, Forbes JM, et al. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003, 41:392-397.
36. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
37. Huang W, Gallois Y, Bouby N, et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc Natl Acad Sci USA 2001, 98:13330-13334.
38. Danser AH, Deinum J, Osterop AP, et al. Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism. J Hypertens 1999, 17:1867-1872.
39. van Dijk MA, Kroon I, Kamper AM, et al. The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm. J Cardiovasc Pharmacol 2000, 35:484-490.
40. Gainer JV, Stein CM, Neal T, et al. Interactive effect of ethnicity and ACE insertion/deletion polymorphism on vascular reactivity. Hypertension 2001, 37:46-51.
41. Bloem LJ, Manatunga AK, Pratt JH Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 1996, 27:62-66.
42. Chakravarti A Population genetics-making sense out of sequence. Nat Genet 1999, 21:56-60.
43. Zhu X, McKenzie CA, Forrester T, et al. Localization of a small genomic region associated with elevated ACE. Am J Hum Genet 2000, 67:1144-1153.
44. van Berlo JH, Pinto YM Polymorphisms in the RAS and cardiac function. Int J Biochem Cell Biol 2003, 35:932-943.
45. Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM, et al. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: A meta-analysis. Stroke 2003, 34:1634-1639.
46. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
47. Holmer SR, Hengstenberg C, Kraft HG, et al. Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction. Circulation 2003, 107:696-701.
48. Jeffers BW, Estacio RO, Raynolds MV, et al. Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int 1997, 52:473-477.
49. Marre M, Jeunemaitre X, Gallois Y, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 1997, 99:1585-1595.
50. Schmidt S, Schone N, Ritz E Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 1995, 47:1176-1181.
51. Chowdhury TA, Dronsfield MJ, Kumar S, et al. Examination of two genetic polymorphisms within the renin-angiotensin system: No evidence for an association with nephropathy in IDDM. Diabetologia 1996, 39:1108-1114.
52. Danser AH, Schalekamp MA, Bax WA, et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995, 92:1387-1388.
53. Davis GK, Millner RW, Roberts DH Angiotensin converting enzyme (ACE) gene expression in the human left ventricle: Effect of ACE gene insertion/deletion polymorphism and left ventricular function. Eur J Heart Fail 2000, 2:253-256.
54. Studer R, Reinecke H, Muller B, et al. Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J Clin Invest 1994, 94:301-310.
55. Spruth E, Zurbrugg HR, Warnecke C, et al. Expression of ACE mRNA in the human atrial myocardium is not dependent on left ventricular function, ACE inhibitor therapy, or the ACE I/D genotype. J Mol Med 1999, 77:804-810.
56. Tamaki S, Iwai N, Ohmichi N, et al. Effect of genotype on the angiotensin-converting enzyme mRNA level in human atria. Clin Exp Pharmacol Physiol 1997, 24:305-308.
57. Jacobsen P, Rossing K, Rossing P, et al. Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy. Kidney Int 1998, 53:1002-1006.
58. Danser AH, Derkx FH, Hense HW, et al. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels. J Hypertens 1998, 16:1879-1883.
59. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: A metaanalysis. Arterioscler Thromb Vasc Biol 2003, 23:1269-1275.
60. Matsubara M, Metoki H, Katsuya T, et al. T+31C polymorphism (M235T) of the angiotensinogen gene and home blood pressure in the Japanese general population: The Ohasama Study. Hypertens Res 2003, 26:47-52.
61. Fogarty DG, Harron JC, Hughes AE, et al. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 1996, 45:1204-1208.
62. Kinoshita JH, Nishimura C The involvement of aldose reductase in diabetic complications. Diabetes Metab Rev 1988, 4:323-337.
63. Buraczynska M, Pijanowski Z, Spasiewicz D, et al. Renin-angiotensin system gene polymorphisms: Assessment of the risk of coronary heart disease. Kardiol Pol 2003, 58:1-9.
64. Nair KG, Shalia KK, Ashavaid TF, et al. Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. J Clin Lab Anal 2003, 17:141-146.
65. Fradin S, Goulet-Salmon B, Chantepie M, et al. Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Diabetes Metab 2002, 28:27-32.
66. Dzida G, Sobstyl J, Puzniak A, et al. Polymorphisms of angiotensin-converting enzyme and angiotensin II receptor type 1 genes in essential hypertension in a Polish population. Med Sci Monit 2001, 7:1236-1241.
67. Tarnow L, Cambien F, Rossing P, et al. Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy. Nephrol Dial Transplant 1996, 11:1019-1023.
68. Ishanov A, Okamoto H, Watanabe M, et al. Angiotensin II type 1 receptor gene polymorphisms in patients with cardiac hypertrophy. Jpn Heart J 1998, 39:87-96.